Key result
Recent evidence supports considering TAVI as the default strategy for the majority of patients, including those at low risk, representing a paradigm shift in valvular heart disease management.
Why the study?
With new evidence for low-risk patients emerging in a rapidly changing field, guidelines must consider whether TAVI should become the default strategy for most patients.
Answers are grounded in this paper and cite their sources.
The article highlights a paradigm shift towards considering TAVI as the default strategy for a majority of patients, including low-risk groups, and emphasizes the essential role of the Heart Team in decision-making.
The field of valve intervention is rapidly changing. Clinical practice guidelines are based on evidence and practical clinical experience. The randomised trials considered for the guideline recommendations regarding indications for TAVI cover the high-risk and intermediate-risk subgroups of patients. With new evidence for low-risk patients, consideration has to be given to discussing TAVI as the default strategy in the majority of patients. This is a paradigm shift from the established practice. More than ever, the patient will be at the centre of the decision making. The Heart Team is essential for optimal patient pathways, as patient factors, longevity and durability considerations have to inform the discussion. Further developments discussed in this article revolve around evidence on secondary mitral regurgitation and mitral edge-to-edge repair.
No takes yet. Share an insight, caveat, or question.
Baumbach et al. (2019) conducted a review in Valvular heart disease. Transcatheter aortic valve implantation (TAVI) and mitral edge-to-edge repair was evaluated. Recent evidence supports considering TAVI as the default strategy for the majority of patients, including those at low risk, representing a paradigm shift in valvular heart disease management.
Synapse has enriched 10 related papers. Consider them for comparative context: